Epizyme

ESMO: A peak at Pfizer's EZH2 inhibitor flashes hope for some

An early look at Pfizer's phase 1 EZH2 inhibitor teased a benefit for prostate cancer and follicular lymphoma but not small cell lung cancer patients.

Max Bayer Sep 11, 2022 6:00am

Person and parachite after landing in snow

Romanelli returns to Merck after brief CEO role—Chutes & Ladders

Apr 22, 2022 9:30am

Fierce Biotech launches layoff tracker—Chutes and Ladders

Apr 8, 2022 9:30am

Epizyme to trim workforce and pipeline in cost-cutting plan

Mar 1, 2022 1:14pm

GlaxoSmithKline GSK House in Brentford UK

GSK kills one of Barron's early darlings, axing Epizyme pact

Feb 9, 2022 6:14am

Merck's Vaxneuvance lead departs for Affinivax—Chutes & Ladders

Aug 13, 2021 9:30am